SCHEMBL8375130

SCHEMBL8375130

CCCCN(C)C=C1CC=NC(N)=C1OC(=O)N(C)C

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
BCHE P06276 4/20 0.33
ACHE P22303 2/20 0.33
NCEH1 Q6PIU2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375866 0.87 NCEH1 (0.33) BCHEACHENCEH1
SCHEMBL8375118 0.86 NCEH1 (0.33) NCEH1
SCHEMBL8374737 0.83 RAB9A (0.34) BCHEACHENCEH1
SCHEMBL8374755 0.79 NCEH1 (0.32) ACHENCEH1
SCHEMBL8378152 0.78
SCHEMBL8375879 0.75 ITGB1 (0.32) BCHEACHE
SCHEMBL8378405 0.74 NCEH1 (0.34) BCHEACHENCEH1
SCHEMBL8376582 0.73 ACHE (0.36) BCHEACHENCEH1
SCHEMBL8375131 0.70 NCEH1 (0.32) NCEH1
Maleic Acid SCHEMBL8375138 0.63 ZDHHC20 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US claimed
US-5869480-A ALLEVIATING MEMORY DYSFUNCTION CHARACTERIZED BY CHOLINERGIC DEFICIT HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5866565-A ALZHEIMER'S DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-02 US disclosed
US-5821239-A USEFUL FOR TREATING ALZHEIMER'S DISEASE CAUSED BY CHOLINERGIC DEFICIT FROMMER LAWRENCE & HUAG LLP (US) 1998-10-13 US disclosed